> White Papers > G+ > Biopharma M&A Tip Sheet
 

Biopharma M&A Tip Sheet

By: G+
G+

Big pharma is approaching a perfect storm As the blockbuster drugs of the past decade drop over the patent cliff, major drug players confront their own shrinking pipelines and increasing scrutiny by the FDA. Small biotech companies developing the next generation of therapeutics are promising growth opportunities. Gerson Lehrman Group, Inc. convened a panel of experts to discuss the perils and opportunities in the coming wave of pharma consolidation. Get the top takeaways from this insightful presentation of M&A strategies focused on growth in the Pharma Industry.

Tags : gerson lehrman group, best practices, emerging markets, business


* Please enter your email address and click the Download Now button to download the white paper.

 Email this page
Published:  May 17, 2011
Length:  2
Type:  White Paper